Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

1.91
-0.0300-1.55%
Post-market: 1.950.0400+2.09%19:58 EDT
Volume:176.21K
Turnover:338.58K
Market Cap:11.57M
PE:-0.16
High:2.00
Open:1.94
Low:1.87
Close:1.94
Loading ...
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities